CUAMC
BMRN icon

China Universal Asset Management Company’s BioMarin Pharmaceuticals BMRN Stock Holding History

China Universal Asset Management Company’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.76M Sell
30,761
-3,368
-10% -$184K 0.11% 144
2026
Q1 		$1.93M Buy
34,129
+2,824
+9% +$165K 0.15% 116
2025
Q4 		$1.86M Sell
31,305
-2,352
-7% -$128K 0.14% 119
2025
Q3 		$1.82M Sell
33,657
-5,233
-13% -$299K 0.15% 121
2025
Q2 		$2.14M Buy
38,890
+250
+0.6% +$14.7K 0.2% 102
2025
Q1 		$2.73M Sell
38,640
-2,144
-5% -$144K 0.25% 87
2024
Q4 		$2.68M Buy
40,784
+3,793
+10% +$254K 0.25% 86
2024
Q3 		$2.6M Buy
36,991
+14,310
+63% +$1.2M 0.29% 74
2024
Q2 		$1.87M Sell
22,681
-13,940
-38% -$1.16M 0.26% 72
2024
Q1 		$3.2M Buy
36,621
+14,465
+65% +$1.29M 0.41% 55
2023
Q4 		$2.14M Buy
22,156
+13,270
+149% +$1.17M 0.42% 65
2023
Q3 		$786K Buy
8,886
+2,372
+36% +$211K 0.23% 89
2023
Q2 		$565K Sell
6,514
-66
-1% -$6.21K 0.17% 105
2023
Q1 		$640K Sell
6,580
-19,350
-75% -$2.01M 0.22% 86
2022
Q4 		$2.68M Sell
25,930
-3,938
-13% -$370K 1.08% 32
2022
Q3 		$2.53M Buy
29,868
+1,737
+6% +$155K 1.07% 36
2022
Q2 		$2.33M Buy
28,131
+21,271
+310% +$1.69M 0.98% 43
2022
Q1 		$529K Buy
+6,860
New +$574K 0.19% 62

Other funds holding BMRN

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
CF
Covea Finance Paris, France $3.17B AUM 35.01% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return

China Universal Asset Management Company's BMRN Position: Q2 2026 in Review

China Universal Asset Management Company reduced its BioMarin Pharmaceuticals (BMRN) stake by 9.9% in Q2 2026, selling an estimated $184K and leaving 30,761 shares worth $1.76M. The position accounts for 0.11% of the portfolio, ranked #144.

China Universal Asset Management Company first reported a position in BMRN in Q1 2022 and has held it in 18 quarters since. The position peaked at $3.2M in Q1 2024. 148 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • China Universal Asset Management Company held 30,761 shares of BioMarin Pharmaceuticals worth $1.76M as of Q2 2026.
  • China Universal Asset Management Company sold 3,368 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $184K.
  • BioMarin Pharmaceuticals made up 0.11% of China Universal Asset Management Company's portfolio in Q2 2026, its #144 holding.
  • China Universal Asset Management Company first reported a position in BioMarin Pharmaceuticals in Q1 2022 and has held it in 18 quarters since.
  • China Universal Asset Management Company's BioMarin Pharmaceuticals position peaked at $3.2M in Q1 2024.
  • 148 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.